UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)

European journal of cancer (1990), 2014-08, Vol.50 (12), p.2090-2098

2014

Link zum Volltext

Verfügbarkeit prüfen

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

BMC cancer, 2021-09, Vol.21 (1), p.1-1018, Article 1018

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers

British journal of cancer, 2011-12, Vol.105 (12), p.1818-1824

2011

Link zum Volltext

Verfügbarkeit prüfen

Adult granulosa cell tumors of the ovary: Tumor dissemination pattern at primary and recurrent situation, surgical outcome

Gynecologic oncology, 2010-11, Vol.119 (2), p.285-290

2010

Link zum Volltext

Verfügbarkeit prüfen

Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?

British journal of cancer, 2013-01, Vol.108 (1), p.32-38

2013

Link zum Volltext

Verfügbarkeit prüfen

Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients

European journal of surgical oncology, 2010-12, Vol.36 (12), p.1202-1210

2010

Link zum Volltext

Verfügbarkeit prüfen

Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base

Gynecologic oncology, 2019-09, Vol.154 (3), p.539-546

2019

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer

Annals of surgical oncology, 2012-04, Vol.19 (4), p.1326-1333

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

Gynecologic oncology, 2023-07, Vol.174, p.80-88

2023

Link zum Volltext

Verfügbarkeit prüfen

Statistical controversies in clinical research: the importance of importance

Annals of oncology, 2016-07, Vol.27 (7), p.1185-1189

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

British journal of cancer, 2011-09, Vol.105 (7), p.890-896

2011

Link zum Volltext

Verfügbarkeit prüfen

627 SCOUT-1: prospective non-interventional study in BRCA/HRD tested ovarian cancer patients eligible for first-line platinum-based chemotherapy

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A258-A258

2021

Link zum Volltext

Verfügbarkeit prüfen

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study

Gynecologic oncology, 2013-02, Vol.128 (2), p.245-251

2013

Link zum Volltext

Verfügbarkeit prüfen

Polymorphism of the IL-8 gene and the risk of ovarian cancer

Cytokine (Philadelphia, Pa.), 2015-02, Vol.71 (2), p.334-338

2015

Link zum Volltext

Verfügbarkeit prüfen

EP809 Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: an analysis of five prospective phase II/III trials of NOGGO metadata base

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A446-A448

2019

Link zum Volltext

Verfügbarkeit prüfen

463 LVSI and Ki67 in prediction of lymph-node metastasis in primary low-grade ovarian cancer

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A191-A192

2020

Link zum Volltext

Verfügbarkeit prüfen

Preoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer

Annals of oncology, 2018-10, Vol.29, p.viii344-viii344

2018

Link zum Volltext

Verfügbarkeit prüfen

469 Survey on the usage of PARP-inhibitor therapy in Germany – a national NOGGO/JAGO-AGO intergroup study

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A239-A239

2021

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives

Geburtshilfe und Frauenheilkunde, 2016-02, Vol.76 (2), p.164-169

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical experience of young patients with small cell ovarian carcinoma of the hypercalcemic type (OSCCHT)

European journal of obstetrics & gynecology and reproductive biology, 2012-12, Vol.165 (2), p.313-317

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO–AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy

Cytokine (Philadelphia, Pa.), 2013-03, Vol.61 (3), p.755-758

2013

Link zum Volltext

Verfügbarkeit prüfen

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Link zum Volltext

Verfügbarkeit prüfen

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Link zum Volltext

Verfügbarkeit prüfen

13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC)

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A10-A10

2020

Link zum Volltext

Verfügbarkeit prüfen

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer

Cytokine (Philadelphia, Pa.), 2008-04, Vol.42 (1), p.77-84

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(56)
Tagungsberichte
(8)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers

Adult granulosa cell tumors of the ovary: Tumor dissemination pattern at primary and recurrent situation, surgical outcome

Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?

Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients

Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base

Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

Statistical controversies in clinical research: the importance of importance

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

627 SCOUT-1: prospective non-interventional study in BRCA/HRD tested ovarian cancer patients eligible for first-line platinum-based chemotherapy

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study

Polymorphism of the IL-8 gene and the risk of ovarian cancer

EP809 Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: an analysis of five prospective phase II/III trials of NOGGO metadata base

463 LVSI and Ki67 in prediction of lymph-node metastasis in primary low-grade ovarian cancer

Preoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer

469 Survey on the usage of PARP-inhibitor therapy in Germany – a national NOGGO/JAGO-AGO intergroup study

PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives

Clinical experience of young patients with small cell ovarian carcinoma of the hypercalcemic type (OSCCHT)

Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO–AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC)

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer

Suchergebnisse filtern